Same Story, Different Decade: How WHO’s Definition of a Global Pandemic Benefits Big Pharma

In the years leading up to 2009, the World Health Organization (WHO) worked alongside vaccine manufacturers, namely GlaxoSmithKline (GSK), to ensure that European and African countries entered into contracts to vaccinate their citizens in the event of an unforeseen global flu pandemic. 

These dormant, or “sleeping contracts,” stipulated that if a global pandemic were to occur, it would trigger the contracts, specified pharmaceutical companies would manufacture flu vaccines and the respective governments would pay the vaccine manufacturers. 

On June 11, 2009, WHO Director-General Margaret Chan declared H1N1 swine flu to be a global pandemic, triggering the dormant contracts and throwing the pharmaceutical and vaccine industry into high gear. 

Chan was able to make this declaration based on WHO’s official definition of a pandemic, which was updated just a month before declaring the H1N1 pandemic — WHO deleted its definition of a pandemic from the organization’s website and replaced it with a new, more flexible definition. 

Under the new definition, WHO no longer required that anyone die from an illness before the organization could declare a pandemic. The new definition stipulated only that infections be geographically widespread. 

At the time WHO declared the H1N1 swine flu a pandemic, only 144 people worldwide had died from the infection. As Wolfgang Wodarg, then chair of the Parliamentary Assembly of the Council of Europe’s Health Committee, explained: 

“The WHO had a definition of a pandemic, which it defined as a virus with high mortality and high morbidity. And in 2009 they suddenly dropped those two characteristics, saying nothing about severity or mortality.” 

Read more: Same Story, Different Decade: How WHO’s Definition of a Global Pandemic Benefits Big Pharma

*** This article has been archived for your research. The original version from David Icke can be found here ***